Nanoparticles can induce ICD through several mechanisms. They can be used to deliver agents that cause oxidative stress, DNA damage, or endoplasmic reticulum stress, all of which can lead to the release of DAMPs. Additionally, nanoparticles can be combined with immune checkpoint inhibitors to enhance the immune response further. The combination of these mechanisms ensures a robust and sustained anti-tumor immune response.
